Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma (Q39115607)
Jump to navigation
Jump to search
scientific article published on 2 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma |
scientific article published on 2 August 2013 |
Statements
1 reference
Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma (English)
1 reference
Enrica Marchi
1 reference
Owen A O'Connor
1 reference
Jennifer E Amengual
1 reference
Sean Clark-Garvey
1 reference
Matko Kalac
1 reference
Luigi Scotto
1 reference
Ellen Neylon
1 reference
Paul Johannet
1 reference
Ying Wei
1 reference
Jasmine Zain
1 reference
2 August 2013
1 reference
1 reference
122
1 reference
12
1 reference
2104-2113
1 reference
Identifiers
1 reference
1 reference